Evidence map›Paper›PMID 24413910›Full record

ArticlePflugers Archiv : European journal of physiology2014

P2X4 receptor regulation of transient receptor potential melastatin type 6 (TRPM6) Mg2+ channels.

Jeroen H F de Baaij, Maxime G Blanchard, Marla Lavrijsen, Jens Leipziger, René J M Bindels, Joost G J Hoenderop

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. SLC41A1 is essential for magnesium homeostasis in vivo.Pflugers Archiv : European journal of physiology · 2019
    Article
  13. The inhibitory role of purinergic P2Y receptor on MgThe journal of physiological sciences : JPS · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. MLKL forms cation channels.Cell research · 2016
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jeroen H F de BaaijDepartment of Physiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
Maxime G Blanchard
Marla Lavrijsen
Jens Leipziger
René J M Bindels
Joost G J Hoenderop
Radboud University Nijmegen · NLRadboud Institute for Molecular Life Sciences · NLAarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transient receptor potential melastatin type 6 (TRPM6) ion channel regulates the body Mg(2+) homeostasis by mediating transcellular Mg(2+) absorption in kidney and intestine. Here, the P2X4 receptor was established as a novel regulator of TRPM6 activity. Using RT-qPCR on a mouse tissue panel, P2x4 and P2x6 were shown to be expressed in the epithelium of the colon and of the kidney, two major sites of Mg(2+) reabsorption. While P2x4 was highly expressed in the colon, both P2x4 and P2x6 mRNA were prominently expressed in the distal convoluted tubule segment of the kidney, a segment with high Trpm6 expression. Using whole-cell patch clamp, an inhibitory role of P2X4 on TRPM6 activity was determined. Expression of P2X6, which does not form functional channels in mammalian cells, did not affect the function of TRPM6. The inhibition was dependent on the activity of P2X4, since a P2X4 mutant with altered ATP sensitivity was not able to inhibit TRPM6. Additionally, P2X4 was unable to inhibit TRPM7, a close homologue of TRPM6, suggesting that the inhibition is specific for TRPM6. To identify the intracellular signaling molecules that mediate the P2X4-dependent inhibition of TRPM6, the cells were treated with inhibitors of protein kinase c, protein kinase a, and phosphoinositide 3-kinase. However, none of these inhibitors prevented the inhibition of TRPM6 by P2X4. In conclusion, we propose that P2X4 receptor mediated purinergic signaling is a new regulatory mechanism of TRPM6 Mg(2+) channels.

Indexed as

AnimalsColonEpithelial CellsHEK293 CellsHumansKidney TubulesMaleMiceMice, Inbred C57BLProtein Kinase InhibitorsReceptors, Purinergic P2X4Signal TransductionTRPM Cation ChannelsProtein Kinase InhibitorsReceptors, Purinergic P2X4Trpm6 protein, mouseTrpm7 protein, mouseTRPM Cation Channels

Identifiers

PMID24413910
OpenAlexW2159196007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.